NCT03000920

Brief Summary

Each year in France, breast cancer affects about 48,000 women and is the first cause of cancer death in women with 11,900 deaths estimated. Since 2004, there is a national organized breast cancer screening (OBCS) programme for asymptomatic women aged 50-74 and with a medium-risk. Every two years, the local cancer screening department sends a personalized invitation mail to eligible women to perform a mammogram and a breast clinical examination. One to two reminder mails are sent to women who have not done the screening after an initial invitation. Despite this programme, almost 47% of women in France do not participate to organized breast cancer screening. The Short Message Service (SMS) is an innovative communication tool in the field of health, immediate, reliable delivery, low cost and ecological. The use of SMS could be an innovative, low-cost, personalized and ecological way to support the OBCS invitation strategy. The overall objective of this study is to preserve or even better increase participation in organized breast cancer screening while decreasing the associated costs by including SMS in our screening invitation procedure. Two SMS interventions will be tested which will correspond to different phases of the OBCS invitation procedure. This sequence of interventions leads us to perform three interlinked trials: a trial of superiority for the first phase (intervention 1: sending an SMS a few days before the initial mail invitation), then two non-inferiority trials for the second phase ( two trials=one for each context of phase 1 \_ intervention 2: sending an SMS in place of the first postal reminder).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,000

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started May 2017

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 22, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

May 2, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
Last Updated

July 18, 2019

Status Verified

July 1, 2019

Enrollment Period

1.6 years

First QC Date

December 12, 2016

Last Update Submit

July 17, 2019

Conditions

Keywords

short message service (SMS)screeningcost-effectiveness

Outcome Measures

Primary Outcomes (2)

  • Phase 1: Compare the participation rates in organized breast cancer screening (and the cost by screened woman) in response to a strategy of sending an SMS before the invitation letter (vs sending the invitation letter alone = usual strategy).

    For this first phase, the study aims to demonstrate that the addition of the SMS is superior in terms of participation and participation costs.

    Before the sending time of the reminder 1 (letter or SMS) : from 3 months to 8 months after the invitation letter depending to periods of the concerned local cancer screening department

  • Phase 2: Compare participation rates in organized breast cancer screening (and the cost by screened woman) in response to a strategy of replacing the reminder 1 by mail with a reminder 1 by SMS ( reminder 1 mail = usual strategy).

    For this second phase, the study aims to demonstrate the non-inferiority of the strategy including the SMS in terms of participation and cost-participation according to the two contexts: * women who have already received an invitation letter alone. * women who have already received one SMS and the invitation mail.

    Before the sending time of the reminder 2 : from 3 months to 6 months after the reminder 1 depending to periods of the concerned local cancer screening department

Study Arms (4)

1_Control

NO INTERVENTION

Classic screening invitation strategy with at least an invitation mail and then one or two reminder by mail if necessary.

2_SMS Reminder 1

EXPERIMENTAL

Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary

Other: SMS Reminder 1

3_SMS before invitation

EXPERIMENTAL

One SMS a few days before the Invitation by mail and then one or two reminder(s) by mail if necessary.

Other: SMS before invitation

4_SMS before invitation + SMS Reminder 1

EXPERIMENTAL

One SMS a few days before the Invitation by mail then reminder 1 by SMS if necessary then reminder 2 by mail if necessary

Other: SMS before invitationOther: SMS Reminder 1

Interventions

A couple of days before the invitation letter, an SMS will be sent to announce the arrival of the invitation letter to the mammogram

3_SMS before invitation4_SMS before invitation + SMS Reminder 1

If it is necessary for the women to have a reminder 1, the usual mail will be replaced by an SMS.

2_SMS Reminder 14_SMS before invitation + SMS Reminder 1

Eligibility Criteria

Age50 Years - 74 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • eligible to the organized breast cancer screening
  • residing in the region of Centre-Val de Loire (France)
  • Phone number registered in data bases of one of the 6 local cancer screening departments of the region of Centre-Val de Loire (France)

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

ADOC41

Blois, France

Location

ADOC28

Chartres, France

Location

CREDEP

Châteauroux, France

Location

CCDC

Tours, 37044, France

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • ken HAGUENOER, Dr

    Centre de Coordination des Dépistages des Cancers, CHRU de Tours

    PRINCIPAL INVESTIGATOR
  • Somany SENGCHANH, Dr

    Centre de Coordination des Dépistages des Cancers, CHRU de Tours

    PRINCIPAL INVESTIGATOR
  • Julie Boyard

    Centre de Coordination des Dépistages des Cancers, CHRU de Tours

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2016

First Posted

December 22, 2016

Study Start

May 2, 2017

Primary Completion

December 1, 2018

Study Completion

June 30, 2019

Last Updated

July 18, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations